|
TWI598347B
(zh)
|
2009-07-13 |
2017-09-11 |
基利科學股份有限公司 |
調節細胞凋亡信號之激酶的抑制劑
|
|
ES2617339T3
(es)
|
2010-12-16 |
2017-06-16 |
Calchan Limited |
Derivados de pirrolopirimidina inhibidores de ASK1
|
|
UY34573A
(es)
|
2012-01-27 |
2013-06-28 |
Gilead Sciences Inc |
Inhibidor de la quinasa que regula la señal de la apoptosis
|
|
WO2015081127A2
(en)
|
2013-11-26 |
2015-06-04 |
Gilead Sciences, Inc. |
Therapies for treating myeloproliferative disorders
|
|
CA2937320A1
(en)
|
2014-01-20 |
2015-07-23 |
Gilead Sciences, Inc. |
Therapies for treating cancers
|
|
WO2015187499A1
(en)
|
2014-06-03 |
2015-12-10 |
Gilead Sciences, Inc. |
Use of an ask1 inhibitor for the treatment of liver disease, optionally in combination with a loxl2 inhibitor
|
|
TW201618781A
(zh)
*
|
2014-08-13 |
2016-06-01 |
吉李德科學股份有限公司 |
治療肺高血壓之方法
|
|
MX2017003933A
(es)
*
|
2014-09-24 |
2017-06-30 |
Gilead Sciences Inc |
Metodos de tratamiento de la enfermedad hepatica.
|
|
MA41252A
(fr)
*
|
2014-12-23 |
2017-10-31 |
Gilead Sciences Inc |
Formes solides d'un inhibiteur d'ask 1
|
|
CN112225699B
(zh)
*
|
2014-12-23 |
2023-11-14 |
吉利德科学公司 |
制备ask1抑制剂的方法
|
|
TW201639573A
(zh)
|
2015-02-03 |
2016-11-16 |
吉李德科學股份有限公司 |
有關治療癌症之合併治療
|
|
US9670205B2
(en)
|
2015-03-04 |
2017-06-06 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
|
PL3456717T3
(pl)
|
2015-07-06 |
2021-10-25 |
Gilead Sciences, Inc. |
Pochodna 4,6-diaminochinolino-3-karbonitrylu jako modulator cot (cancer osaka thyroid) do leczenia choroby zapalnej
|
|
US20190054090A1
(en)
|
2015-10-01 |
2019-02-21 |
Gilead Sciences, Inc. |
Combination of a btk inhibitor and a checkpoint inhibitor for treating cancers
|
|
HK1258762A1
(zh)
*
|
2015-10-02 |
2019-11-22 |
Gilead Sciences, Inc. |
Btk抑制剂gs-4059与选自jak、ask1、brd和/或mmp9抑制剂的抑制剂的组合，以治疗癌症、过敏性病症、自身免疫疾病或发炎性疾病
|
|
CU20180059A7
(es)
|
2015-12-17 |
2018-10-04 |
Gilead Sciences Inc |
Compuestos inhibidores de la quinasa de unión a tank
|
|
AU2017228371A1
(en)
|
2016-03-04 |
2018-09-13 |
Gilead Sciences, Inc. |
Compositions and combinations of autotaxin inhibitors
|
|
EP3440113A1
(en)
|
2016-04-08 |
2019-02-13 |
Gilead Sciences, Inc. |
Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
|
|
UA126905C2
(uk)
|
2016-06-13 |
2023-02-22 |
Ай-Маб Байофарма Юес Лімітед |
Антитіло до pd-l1 та його застосування
|
|
CA3032813A1
(en)
|
2016-08-04 |
2018-02-08 |
Gilead Sciences, Inc. |
Cobicistat for use in cancer treatments
|
|
WO2018045150A1
(en)
|
2016-09-02 |
2018-03-08 |
Gilead Sciences, Inc. |
4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
|
|
AU2017318601B2
(en)
|
2016-09-02 |
2020-09-03 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
|
US20180133212A1
(en)
|
2016-11-03 |
2018-05-17 |
Gilead Sciences, Inc. |
Combination of a bcl-2 inhibitor and a bromodomain inhibitor for treating cancer
|
|
CA3042398A1
(en)
|
2016-11-11 |
2018-05-17 |
Gilead Sciences, Inc. |
Methods of treating liver disease
|
|
WO2018097977A1
(en)
|
2016-11-22 |
2018-05-31 |
Gilead Sciences, Inc. |
Crystalline forms of a phosphate complex of a bet inhibitor
|
|
AR110252A1
(es)
|
2016-11-30 |
2019-03-13 |
Gilead Sciences Inc |
Compuestos heterocíclicos fusionados como inhibidores de la quinasa cam
|
|
JP6754505B2
(ja)
*
|
2017-01-22 |
2020-09-09 |
福建広生堂薬業股▲ふん▼有限公司 |
Ａｓｋ１阻害剤、その調製方法および使用
|
|
WO2018133866A1
(zh)
*
|
2017-01-22 |
2018-07-26 |
福建广生堂药业股份有限公司 |
作为ask1抑制剂的吡啶衍生物及其制备方法和应用
|
|
CA3045376C
(en)
|
2017-01-24 |
2022-08-30 |
I-Mab |
Anti-cd73 antibodies and uses thereof
|
|
US10314844B2
(en)
|
2017-02-24 |
2019-06-11 |
Gilead Sciences, Inc. |
Inhibitors of Bruton's tyrosine kinase
|
|
AU2018224136B2
(en)
|
2017-02-24 |
2021-10-21 |
Gilead Sciences, Inc. |
Inhibitors of Bruton's Tyrosine Kinase
|
|
WO2018157277A1
(en)
*
|
2017-02-28 |
2018-09-07 |
Eli Lilly And Company |
Isoquinolin and naphthydrin compounds
|
|
US11136324B2
(en)
|
2017-03-03 |
2021-10-05 |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. |
Substituted imidazoles as apoptosis signal regulating kinase 1 inhibitors
|
|
WO2018169742A1
(en)
|
2017-03-14 |
2018-09-20 |
Gilead Sciences, Inc. |
Apoptosis signal-regulating kinase inhibtor
|
|
JP2020512342A
(ja)
|
2017-03-28 |
2020-04-23 |
ギリアード サイエンシーズ， インコーポレイテッド |
肝疾患を処置する方法
|
|
JP2020516627A
(ja)
|
2017-04-12 |
2020-06-11 |
ギリアード サイエンシーズ， インコーポレイテッド |
肝疾患を処置する方法
|
|
BR102018007822A2
(pt)
|
2017-04-20 |
2018-11-06 |
Gilead Sciences, Inc. |
composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
|
|
AU2018266911C1
(en)
|
2017-05-12 |
2022-10-20 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
US10246439B2
(en)
|
2017-05-25 |
2019-04-02 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2018218051A1
(en)
*
|
2017-05-25 |
2018-11-29 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2018218042A1
(en)
*
|
2017-05-25 |
2018-11-29 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
US10495648B2
(en)
|
2017-06-13 |
2019-12-03 |
Gilead Sciences, Inc. |
Methods of treating liver fibrosis
|
|
TW201908306A
(zh)
*
|
2017-07-18 |
2019-03-01 |
大陸商南京聖和藥業股份有限公司 |
作為ask抑制劑的雜環化合物及其應用
|
|
US10597382B2
(en)
|
2017-08-28 |
2020-03-24 |
Enanta Pharmaceuticals, Inc. |
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
CN109456308B
(zh)
*
|
2017-09-06 |
2022-11-29 |
南京圣和药业股份有限公司 |
作为ask抑制剂的杂环化合物及其应用
|
|
US10370352B2
(en)
|
2017-09-07 |
2019-08-06 |
Eli Lilly And Company |
Cyclobutyl-imidazolidinone compounds
|
|
WO2019047094A1
(en)
*
|
2017-09-07 |
2019-03-14 |
Eli Lilly And Company |
CYCLOBUTYL-IMIDAZOLIDINONE COMPOUNDS
|
|
WO2019047161A1
(en)
|
2017-09-08 |
2019-03-14 |
Eli Lilly And Company |
IMIDAZOLIDINE COMPOUNDS
|
|
EP3678662A4
(en)
|
2017-09-08 |
2021-09-01 |
Fronthera U.S. Pharmaceuticals LLC |
APOPTOSIS SIGNAL REGULATION KINASE INHIBITORS AND THEIR USES
|
|
CN111518080A
(zh)
*
|
2017-10-12 |
2020-08-11 |
深圳市塔吉瑞生物医药有限公司 |
一种1,2,4-三氮唑类化合物
|
|
CN107793400B
(zh)
*
|
2017-10-31 |
2020-01-31 |
武汉九州钰民医药科技有限公司 |
吡啶类化合物及其在制备治疗肝脏疾病的药物中的应用
|
|
EP3710599B1
(en)
|
2017-11-13 |
2024-07-17 |
Gilead Sciences, Inc. |
Method for staging liver fibrosis in nash patients
|
|
WO2019123339A1
(en)
|
2017-12-20 |
2019-06-27 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
EP3728283B1
(en)
|
2017-12-20 |
2023-11-22 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
3'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
EP3735404B1
(en)
|
2018-01-02 |
2023-11-29 |
Seal Rock Therapeutics, Inc. |
Ask1 inhibitor compounds and uses thereof
|
|
CR20200347A
(es)
|
2018-02-13 |
2020-09-23 |
Gilead Sciences Inc |
Inhibidores pd-1/pd-l1
|
|
CN110294742B
(zh)
*
|
2018-03-21 |
2023-01-31 |
山东轩竹医药科技有限公司 |
并环类ask1抑制剂及其应用
|
|
TWI833744B
(zh)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-環二核苷酸
|
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
２，２，─環二核苷酸
|
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
|
TW202012414A
(zh)
*
|
2018-04-12 |
2020-04-01 |
美商拓臻股份有限公司 |
三環ask1抑制劑
|
|
TWI712412B
(zh)
|
2018-04-19 |
2020-12-11 |
美商基利科學股份有限公司 |
Pd‐1/pd‐l1抑制劑
|
|
CN110407806B
(zh)
*
|
2018-04-28 |
2021-08-17 |
深圳微芯生物科技股份有限公司 |
甲酰胺类化合物、其制备方法及其应用
|
|
ES3004523T3
(en)
|
2018-05-02 |
2025-03-12 |
Enanta Pharm Inc |
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2019213239A1
(en)
|
2018-05-02 |
2019-11-07 |
Enanta Pharmaceuticals Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
US20190359645A1
(en)
|
2018-05-03 |
2019-11-28 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides comprising carbocyclic nucleotide
|
|
JP2021523151A
(ja)
|
2018-05-11 |
2021-09-02 |
ホスホレックス、インコーポレイテッド |
負の表面電荷を有するマイクロ粒子及びナノ粒子
|
|
KR102551319B1
(ko)
|
2018-05-14 |
2023-07-05 |
길리애드 사이언시즈, 인코포레이티드 |
Mcl-1 억제제
|
|
WO2020006429A1
(en)
*
|
2018-06-28 |
2020-01-02 |
Hepatikos Therapeutics, Llc |
Ask1 isoindolin-1-one inhibitors and methods of use thereof
|
|
SG11202012425QA
(en)
|
2018-07-13 |
2021-01-28 |
Gilead Sciences Inc |
Pd-1/pd-l1 inhibitors
|
|
CN112638912B
(zh)
*
|
2018-07-20 |
2022-04-26 |
福建广生中霖生物科技有限公司 |
作为ask1抑制剂的晶型及其制备方法和应用
|
|
WO2020041417A1
(en)
|
2018-08-22 |
2020-02-27 |
Enanta Pharmaceuticals, Inc. |
Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
EP3860717A1
(en)
|
2018-10-03 |
2021-08-11 |
Gilead Sciences, Inc. |
Imidozopyrimidine derivatives
|
|
KR102298546B1
(ko)
|
2018-10-18 |
2021-09-08 |
에이치케이이노엔 주식회사 |
신규한 n-(이소프로필-트리아졸릴)피리디닐)-헤테로아릴-카르복사미드 유도체 및 이의 용도
|
|
WO2020086556A1
(en)
|
2018-10-24 |
2020-04-30 |
Gilead Sciences, Inc. |
Pd-1/pd-l1 inhibitors
|
|
WO2020092528A1
(en)
|
2018-10-31 |
2020-05-07 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity
|
|
US11203591B2
(en)
|
2018-10-31 |
2021-12-21 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds
|
|
CN111170995A
(zh)
*
|
2018-11-09 |
2020-05-19 |
山东轩竹医药科技有限公司 |
Ask1抑制剂及其应用
|
|
WO2020106707A1
(en)
|
2018-11-19 |
2020-05-28 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
CN109608441A
(zh)
*
|
2018-12-26 |
2019-04-12 |
都创(上海)医药科技有限公司 |
一种ask1抑制剂的合成工艺
|
|
PT3911647T
(pt)
|
2019-01-15 |
2024-03-04 |
Gilead Sciences Inc |
Composto de isoxazole como agonista de fxr e composições farmacêuticas que o contenham
|
|
CN109813915A
(zh)
*
|
2019-02-15 |
2019-05-28 |
浠思（上海）生物技术有限公司 |
利用htrf一步法筛选激酶抑制剂的方法
|
|
JP2022519906A
(ja)
|
2019-02-19 |
2022-03-25 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｆｘｒアゴニストの固体形態
|
|
EP3934757B1
(en)
|
2019-03-07 |
2023-02-22 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
2'3'-cyclic dinucleotides and prodrugs thereof
|
|
WO2020178768A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
|
WO2020178770A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
|
JP7697885B2
(ja)
|
2019-03-11 |
2025-06-24 |
ギリアード サイエンシーズ， インコーポレイテッド |
化合物の製剤およびそれらの使用
|
|
US11466033B2
(en)
|
2019-03-25 |
2022-10-11 |
Enanta Pharmaceuticals, Inc. |
Substituted pyridines as apoptosis signal-regulating kinase 1 inhibitors
|
|
TWI751516B
(zh)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TW202212339A
(zh)
|
2019-04-17 |
2022-04-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
EP3972695A1
(en)
|
2019-05-23 |
2022-03-30 |
Gilead Sciences, Inc. |
Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
|
|
TWI770527B
(zh)
|
2019-06-14 |
2022-07-11 |
美商基利科學股份有限公司 |
Cot 調節劑及其使用方法
|
|
CA3140708A1
(en)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
|
WO2020263830A1
(en)
|
2019-06-25 |
2020-12-30 |
Gilead Sciences, Inc. |
Flt3l-fc fusion proteins and methods of use
|
|
WO2020261294A1
(en)
*
|
2019-06-26 |
2020-12-30 |
Mankind Pharma Ltd. |
Novel apoptosis signal-regulating kinase 1 inhibitors
|
|
AR119594A1
(es)
|
2019-08-09 |
2021-12-29 |
Gilead Sciences Inc |
Derivados de tienopirimidina como inhibidores acc y usos de los mismos
|
|
ES2973832T3
(es)
|
2019-10-18 |
2024-06-24 |
Forty Seven Inc |
Terapias combinadas para el tratamiento de síndromes mielodisplásicos y leucemia mieloide aguda
|
|
JP2022552748A
(ja)
|
2019-10-31 |
2022-12-19 |
フォーティ セブン， インコーポレイテッド |
抗ｃｄ４７及び抗ｃｄ２０による血液癌の治療
|
|
TWI778443B
(zh)
|
2019-11-12 |
2022-09-21 |
美商基利科學股份有限公司 |
Mcl1抑制劑
|
|
EP4058144A1
(en)
|
2019-11-15 |
2022-09-21 |
Gilead Sciences, Inc. |
Triazole carbamate pyridyl sulfonamides as lpa receptor antagonists and uses thereof
|
|
CN111018831B
(zh)
*
|
2019-11-21 |
2022-05-31 |
中国药科大学 |
细胞凋亡信号调节激酶抑制剂及其应用
|
|
US20230105984A1
(en)
|
2019-12-23 |
2023-04-06 |
Svetlana Marukian |
Compositions and methods for the treatment of liver diseases and disorders
|
|
IL294032A
(en)
|
2019-12-24 |
2022-08-01 |
Carna Biosciences Inc |
Compounds that regulate diacylglycerol kinase
|
|
TWI890283B
(zh)
|
2020-02-14 |
2025-07-11 |
美商基利科學股份有限公司 |
結合ccr8之抗體及融合蛋白及其用途
|
|
CA3175541A1
(en)
|
2020-03-30 |
2021-10-07 |
Gilead Sciences, Inc. |
Solid forms of (s)-6-(((1-(bicyclo[1.1.1]pentan-1-yl)-1h-1,2,3-triazol-4-yl)2-methyl-1-oxo-1,2- dihydroisoquinolin-5-yl)methyl)))amino)8-chloro-(neopentylamino)quinoline-3-carb onitrile a cot inhibitor compound
|
|
JP7446475B2
(ja)
|
2020-04-02 |
2024-03-08 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｃｏｔ阻害剤化合物を調製するためのプロセス
|
|
IL297327B2
(en)
|
2020-05-01 |
2026-01-01 |
Gilead Sciences Inc |
4,2-dioxopyrimidine compounds CD73 inhibitors
|
|
EP4161936A1
(en)
|
2020-06-03 |
2023-04-12 |
Gilead Sciences, Inc. |
Lpa receptor antagonists and uses thereof
|
|
CN113831323B
(zh)
*
|
2020-06-24 |
2025-08-29 |
武汉人福创新药物研发中心有限公司 |
芳杂环酰胺类化合物及其用途
|
|
CN111808079A
(zh)
*
|
2020-08-05 |
2020-10-23 |
中国药科大学 |
吲哚类ask1小分子抑制剂及其制备方法和应用
|
|
CN114470217B
(zh)
*
|
2020-11-24 |
2023-06-20 |
深圳微芯生物科技股份有限公司 |
预防和治疗代谢异常或炎症引起的组织损伤的药物组合物
|
|
WO2022192428A1
(en)
|
2021-03-11 |
2022-09-15 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
EP4681774A3
(en)
|
2021-03-29 |
2026-03-25 |
Gilead Sciences, Inc. |
Khk inhibitors
|
|
TW202302145A
(zh)
|
2021-04-14 |
2023-01-16 |
美商基利科學股份有限公司 |
ＣＤ４７／ＳＩＲＰα結合及ＮＥＤＤ８活化酶Ｅ１調節次單元之共抑制以用於治療癌症
|
|
CN114246866B
(zh)
*
|
2021-04-28 |
2023-09-12 |
深圳微芯生物科技股份有限公司 |
用于治疗慢性肾病的药物及其用途
|
|
WO2022240879A1
(en)
|
2021-05-11 |
2022-11-17 |
Gilead Sciences, Inc. |
Lpa receptor antagonists and uses thereof
|
|
KR20240007233A
(ko)
|
2021-05-13 |
2024-01-16 |
길리애드 사이언시즈, 인코포레이티드 |
Lpa 수용체 길항제 및 이의 용도
|
|
WO2022245671A1
(en)
|
2021-05-18 |
2022-11-24 |
Gilead Sciences, Inc. |
Methods of using flt3l-fc fusion proteins
|
|
TW202345826A
(zh)
|
2021-06-04 |
2023-12-01 |
美商基利科學股份有限公司 |
治療nash之方法
|
|
TW202311256A
(zh)
|
2021-06-18 |
2023-03-16 |
美商基利科學股份有限公司 |
用於治療ｆｘｒ誘發之搔癢之ｉｌ－３１調節劑
|
|
AU2022299051B2
(en)
|
2021-06-23 |
2025-03-13 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
JP7651018B2
(ja)
|
2021-06-23 |
2025-03-25 |
ギリアード サイエンシーズ， インコーポレイテッド |
ジアシルグリセロールキナーゼ調節化合物
|
|
JP7686091B2
(ja)
|
2021-06-23 |
2025-05-30 |
ギリアード サイエンシーズ， インコーポレイテッド |
ジアシルグリセロールキナーゼ調節化合物
|
|
MX2023014762A
(es)
|
2021-06-23 |
2024-01-15 |
Gilead Sciences Inc |
Compuestos moduladores de diacilglicerol quinasa.
|
|
AU2022375782B2
(en)
|
2021-10-28 |
2026-02-26 |
Gilead Sciences, Inc. |
Pyridizin-3(2h)-one derivatives
|
|
JP7787991B2
(ja)
|
2021-10-29 |
2025-12-17 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｃｄ７３化合物
|
|
WO2023107956A1
(en)
|
2021-12-08 |
2023-06-15 |
Dragonfly Therapeutics, Inc. |
Proteins binding nkg2d, cd16 and 5t4
|
|
WO2023107938A1
(en)
|
2021-12-08 |
2023-06-15 |
Gilead Sciences, Inc. |
Lpa receptor antagonists and uses thereof
|
|
US20230220106A1
(en)
|
2021-12-08 |
2023-07-13 |
Dragonfly Therapeutics, Inc. |
Antibodies targeting 5t4 and uses thereof
|
|
US12122764B2
(en)
|
2021-12-22 |
2024-10-22 |
Gilead Sciences, Inc. |
IKAROS zinc finger family degraders and uses thereof
|
|
KR20240123836A
(ko)
|
2021-12-22 |
2024-08-14 |
길리애드 사이언시즈, 인코포레이티드 |
이카로스 아연 핑거 패밀리 분해제 및 이의 용도
|
|
TW202340168A
(zh)
|
2022-01-28 |
2023-10-16 |
美商基利科學股份有限公司 |
Ｐａｒｐ７抑制劑
|
|
WO2023178181A1
(en)
|
2022-03-17 |
2023-09-21 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
|
KR20240165995A
(ko)
|
2022-03-24 |
2024-11-25 |
길리애드 사이언시즈, 인코포레이티드 |
Trop-2 발현 암의 치료를 위한 병용요법
|
|
TWI876305B
(zh)
|
2022-04-05 |
2025-03-11 |
美商基利科學股份有限公司 |
用於治療結腸直腸癌之組合療法
|
|
CR20240451A
(es)
|
2022-04-21 |
2024-12-04 |
Gilead Sciences Inc |
Compuestos de modulación de kras g12d
|
|
KR20250028371A
(ko)
|
2022-07-01 |
2025-02-28 |
길리애드 사이언시즈, 인코포레이티드 |
Cd73 화합물
|
|
WO2024064668A1
(en)
|
2022-09-21 |
2024-03-28 |
Gilead Sciences, Inc. |
FOCAL IONIZING RADIATION AND CD47/SIRPα DISRUPTION ANTICANCER COMBINATION THERAPY
|
|
AU2023409398A1
(en)
|
2022-12-22 |
2025-06-05 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
CN115844887B
(zh)
*
|
2022-12-28 |
2023-09-08 |
中国人民解放军空军军医大学 |
Selonsertib在制备治疗癌症的药物中的用途
|
|
AU2024252725A1
(en)
|
2023-04-11 |
2025-11-06 |
Gilead Sciences, Inc. |
Kras modulating compounds
|
|
CR20250446A
(es)
|
2023-04-21 |
2025-12-02 |
Gilead Sciences Inc |
Inhibidores de prmt5 y usos de los mismos
|
|
WO2024236595A1
(en)
*
|
2023-05-18 |
2024-11-21 |
Council Of Scientific And Industrial Research |
Protacs for ask1 protein degradation: preparation and use thereof
|
|
AU2024306338A1
(en)
|
2023-06-30 |
2026-01-08 |
Gilead Sciences, Inc. |
Kras modulating compounds
|
|
KR20250010571A
(ko)
|
2023-07-12 |
2025-01-21 |
한국화학연구원 |
신규한 고리 구조의 트리아졸 화합물, 이의 제조방법 및 이의 용도
|
|
KR20260046403A
(ko)
|
2023-07-26 |
2026-04-07 |
길리애드 사이언시즈, 인코포레이티드 |
Parp7 저해제
|
|
CN121620513A
(zh)
|
2023-07-26 |
2026-03-06 |
吉利德科学公司 |
Parp7抑制剂
|
|
US20250101042A1
(en)
|
2023-09-08 |
2025-03-27 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
US20250109147A1
(en)
|
2023-09-08 |
2025-04-03 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
US20250154172A1
(en)
|
2023-11-03 |
2025-05-15 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
WO2025137640A1
(en)
|
2023-12-22 |
2025-06-26 |
Gilead Sciences, Inc. |
Azaspiro wrn inhibitors
|
|
WO2025245003A1
(en)
|
2024-05-21 |
2025-11-27 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
US20260098049A1
(en)
|
2024-08-12 |
2026-04-09 |
Gilead Sciences, Inc. |
Kras modulating compounds
|